November 28, 2022

In collaboration with researchers in Wurzburg, Germany, Atuka has co-authored a new paper that further characterises the AAV-A53T-aSyn rat model of Parkinson’s disease. Atuka extensively uses this model to evaluate potential therapies for Parkinson’s disease. The full paper is available here.

Description & References:

Product Spec:

CAS No.:

Molecular Structure: